CCBC second quarter 2013 revenues increase 30.5% to RMB128.5 million
| 20 Nov 2012 17:46 | News-Medical.net |
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited ...